Don't think we will need GG to chip in. The terms now appear to generous. See you been doing some research, re Rux Refractory Adults. If the team leader at the FDA likes his job , I would bet he is asking the question. "Can we also approve Rux Refractory Adults? They need it . We can look at the data in 12 months. Do another trial if you wish as second line therapy. "
MSB Price at posting:
$1.83 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)